Clinical Trials

Ongoing clinical trials in molecular imaging and radiotheranostics. Sorted by date of last update.

Title Phase Last Update

Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial

Early Phase 1

Last update: March 10

Early Phase 1 March 10

Phase 2 Randomized Trial of Flexible Dosing Schedule of Lu-177-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)

Phase 2

Last update: March 10

Phase 2 March 10

Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study

Phase 2

Last update: March 10

Phase 2 March 10

The Safety, Dosimetry and Efficacy of Lu-177-INN805 in Patients with Malignant Solid Tumors

Early Phase 1

Last update: March 10

Early Phase 1 March 10

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu-177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

Phase 2

Last update: March 10

Phase 2 March 10

Yttrium Y-90 Radioembolization in Treating Patients with Metastatic Liver Cancer

Phase 1

Last update: March 10

Phase 1 March 10

Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones

Phase 2

Last update: March 10

Phase 2 March 10

Testing the Addition of An Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiation-Based Treatment (Lutetium Lu-177 Dotatate) for Pancreatic Neuroendocrine Tumors

Phase 1

Last update: March 10

Phase 1 March 10

Radium-223 in Biochemically Recurrent Prostate Cancer

Phase 2

Last update: March 10

Phase 2 March 10

Comparing Retreatment of Lu-177-DOTATATE PRRT versus the Usual Treatment in Patients with Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial

Phase 2

Last update: March 10

Phase 2 March 10